Acquisition of the Belgian provider of brachytherapy accessories BrachySolutions BVBA, Leuven
Acquisition of the Brazilian medical transport specialist BR-77 Comércio, Distribuidora e Transportes de Medicamentos Ltda. in São Paulo
Eckert & Ziegler acquires a minority interest in Cuarsight, Copenhague (DK), a company specialized in radiopharmaceuticals for nuclear medicine
Sale of US seed business
Eckert & Ziegler sells its shares in OctreoPharm Sciences to the French pharmaceutical company IPSEN
Eckert & Ziegler takes over the Isotope business unit of the Brazilian REM Indústria e Comércio Ltda. in São Paulo
Eckert & Ziegler acquires manufacturer of brachytherapy instrumentation and accessories Mick Radio Nuclear Instruments, Inc., Mount Vernon (NY)
Eckert & Ziegler acquires the prostate cancer implants business of the American company Biocompatibles Inc., Oxford (CT)
Eckert & Ziegler acquires a minority interest in OctreoPharm Sciences GmbH, Berlin, a company specialized in radiopharmaceuticals for nuclear medicine
Eckert & Ziegler acquires BSM Diagnostica Gesellschaft m.b.H., Vienna, Austria
Eckert & Ziegler acquire EnergySolution’s UK sources and waste business (Didcot, UK)
Acquisition of Chemotrade Chemiehandelsgesellschaft mbH, Düsseldorf
Acquisition of the pharmaceutical service provider Vitalea Science Inc., Davis (CA)
Eckert & Ziegler acquires the Analytic Instrumentation and Radiochemistry Equipment Business from American market leader Bioscan, Inc.
Eckert & Ziegler takes over the Belgian IBt and holds 72% of the shares.
Acquisition of the isotope specialist Nuclitec GmbH, Braunschweig.
The Californian subsidiary Eckert & Ziegler Isotope Products, Inc. acquires the sealed source business of North American Scientific.
Eckert & Ziegler transfers the shares of Eckert & Ziegler Bebig GmbH into the Belgian brachytherapy specialist IBt s.a. and holds 29,9% of the IBt shares.
Acquisition of the radiopharmaceutical producer MC Pharma GmbH, Bonn.
The Californian subsidiary Eckert & Ziegler Isotope Products, Inc. acquires all shares of Analytics, Atlanta, Georgia (USA).
Acquisition of 51% of the shares of f-con Europe GmbH.
Acquisition of 70% of EURO-PET Berlin Zyklotron GmbH, Berlin.
Acquisition of MMI, the radiation product business of HEK GmbH, Lübeck.
Acquisition of a majority stake in sales subsidiary, Isotope Products Europe Blaseg (IPE) GmbH, Waldburg.
Acquisition of the radiation equipment division of CIS bio International, France.
Acceptance of the Eckert & Ziegler share in the Prime Standard category of the Frankfurt Stock Exchange.
Acquisition of the Worldwide Sources Business from DuPont Pharmaceuticals, Boston. Radioactive industrial and nuclear medicine products.
Acquisition of shares of Isotope Products Europe Blaseg (IPE) GmbH, Waldburg. Distribution of radiation sources for industrial applications.
Stock market listing on the New Market, Frankfurt.
Acquisition of Isotope Products Laboratories (IPL) Inc., California. Development and production of radiation sources for industrial, scientific and medical applications.
Founding of Eckert & Ziegler Strahlen- und Medizintechnik AG, Berlin as a holding company for a number of specialized subsidiaries. Processing of radioisotopes as well as development, manufacturing and distribution of components using isotope technology, medical devices or related products.
Founding of EUROTOPE Entwicklungsgesellschaft für Isotopentechnologien mbH, Berlin. Development of production lines, special sources and recycling processes for radioactive materials.
Participation in Cesio s.r.o, Prague. Production of preliminary products and industrial radiation sources.
Founding of BEBIG Isotopentechnik und Umweltdiagnostik GmbH (BEBIG GmbH), Berlin by Dr. Andreas Eckert and Jürgen Ziegler. BEBIG GmbH was preceded by the Zentralinstitut für Isotopentechnik, a research institute of the former Academy of Sciences of the GDR. Manufacturing of weak sources of radiation for industrial and medical purposes.